| Aabo, Gitte (Leo Pharma 201511 CEO) |
Chief Executive Officer (CEO) |
Leo Pharma (Group) |
Denmark |
| Aamund, Asger (Bavarian Nordic 200804 Chairman) |
n. a. |
Bavarian Nordic (Group) |
Denmark |
| Aasen, Ove T. (DiaMan AS 201804 CEO) |
Chief Executive Officer (CEO) |
DiaMan AS |
Norway |
| Aastrup, Teodor (Attana 200502) |
n. a. |
Attana (Group) |
Sweden |
| Aastveit, Are (Norwegian University for Biosciences and the Environment 200601) |
n. a. |
Norwegian University of Life Sciences (UMB) |
Norway |
| Abrams, Judith R. (Editas Medicine 201910– CMO before EMD Serono RnD Institute + CorMedix + Celgene + Novo Nordisk) |
Chief Medical Officer (CMO) |
Editas Medicine Inc. (Nasdaq: EDIT) |
United States (USA) |
| Adams, Nicholas (Clavis Pharma 201107– CBO before Antisoma since 1999 BusDev Director + Manager + Ciba-Geiga + Eisai) |
Chief Business Officer (CBO) |
Aqualis ASA |
Norway |
| Adlersson, Lars (Medivir 200609 CEO + President) |
Chief Executive Officer (CEO) |
Medivir (Group) |
Sweden |
| af Winklerfelt, Michael (Oasmia 202008 CFO) |
Chief Financial Officer (CFO) |
Oasmia Pharmaceutical AB |
Sweden |
| Agger, Mette Kirstine (Lundbeck 201411 Managing Partner at Lundbeckfonden Ventures before 7TM Pharma CEO) |
Managing Partner (investment firm) |
Lundbeck (Group) |
Denmark |
| Aguiar-Lucander, Renée (Pharmalink AB 201708 CEO) |
Chief Executive Officer (CEO) |
Calliditas Therapeutics (Group) |
Sweden |
| Ahanola, Jani (Noona Healthcare 201611 CEO) |
Chief Executive Officer (CEO) |
Noona Healthcare (FI) |
Finland |
| Ahomäki, Satu (Orion Corp 202001 SVP Commercial Operations) |
Chief Commercial Officer (CCO) |
Orion Corporation (Group) |
Finland |
| Aiolfi, Franco (Biohit 201304– CEO of Biohit Italy before EuroClone) |
Chief Executive Officer (CEO) |
Biohit (Group) |
Italy |
| Akay, Ingrid Teigland (Hadean Ventures 201604 Managing Director) |
Managing Director |
Hadean Ventures (NO) |
Norway |
| Alajmovic, Sana (Sigrid Therapeutics 201909 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Sigrid Therapeutics AB |
Sweden |
| Alamaa, Marie-Louise (PledPharma 202011 CFO) |
Chief Financial Officer (CFO) |
Egetis Therapeutics (Group) |
Sweden |
| Albers, Jeffrey W. (Jeff) (Blueprint Medicinces 201201– President of Algeta US + Genzyme + Mintz Levin) |
Chief Executive Officer (CEO) |
Blueprint Medicines (Group) |
United States (USA) |
| Albertella, Mark (Storm Therapeutics 201905– VP Translational Oncology before Medivir + Argenta + OSI Pharmaceuticals) |
Research & Development Manager |
Storm Therapeutics Ltd. |
United Kingdom (GB) |
| Albinus, Bjørn (Cheminova 200504 Managing Director) |
Managing Director |
Auriga Industries (Group) |
Denmark |
| Albrecht, Claudio (Actavis 201201 CEO) |
Chief Executive Officer (CEO) |
Teva (Group) |
Iceland |
| Albrecht, Uwe (Mediconomics 201704 Managing Director) |
Managing Director |
Mediconomics GmbH |
Germany |
| Albrechtsen, Morten (Nanovi ApS 201311 CEO + Co-founder) |
Chief Executive Officer (CEO) |
Nanovi A/S |
Denmark |
| Alenfall, Jan (Follicum 201902 CEO) |
Chief Executive Officer (CEO) |
Follicum AB |
Sweden |
| Alevizopoulos, Konstantinos (APIM Therapeutics 201210 CEO) |
Chief Executive Officer (CEO) |
APIM Therapeutics AS |
Norway |
| Alfheim, Jan A. (Oncoinvent 202006 CEO) |
Chief Executive Officer (CEO) |
Oncoinvent AS |
Norway |
| Alsbo, Carsten (Exiqon 200904 Product Manager) |
Product Manager (personnel) |
Qiagen (Group) |
Denmark |
| Álvarez-Martos, Isabel (Cellugy 202012 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cellugy (DK) |
Denmark |
| Anand, Ravi (Newron Pharmaceuticals 201103 CMO) |
Chief Medical Officer (CMO) |
Newron (Group) |
Italy |
| Andersén, Hedvig (Sweden (govt) 201201 Life Science Investment Manager at Industrifonden) |
Investment Manager |
Sweden (govt) |
Sweden |
| Andersen, Peder M. (Biosergen 202104 CEO) |
Chief Executive Officer (CEO) |
Biosergen AB |
Sweden |
| Andersen, Thomas (Nextera AS 201510 CEO) |
Chief Executive Officer (CEO) |
Nextera AS |
Norway |
| Andersin, Kati (Biohit 200905 Product Group Manager) |
Product Manager (personnel) |
Biohit (Group) |
Finland |
| Andersson, Ann-Sofie (Copenhagen (govt) 201701 Business Development Manager Life Sciences at Copenhagen Capacity) |
Business Development Manager / Strategy Manager |
Copenhagen (govt region) |
Denmark |
| Andersson, Claus A. (Sunstone Capital 201511 Partner Life Sciences) |
Partner (venture partner) |
Sunstone Life Science (Group) |
Denmark |
| Andersson, Poul (DTU 201404 CEO of Bioneer A/S) |
Chief Executive Officer (CEO) |
Technical University of Denmark (DTU) |
Denmark |
| Andersson, Thomas (Lund Univ 201202 CEO of LU Bio) |
Chief Executive Officer (CEO) |
University of Lund (Lund University) |
Sweden |
| Andréasson, Sven (Active Biotech 199901–200808 President + CEO) |
Chief Executive Officer (CEO) |
Active Biotech (Group) |
Sweden |
| Andreu, Fernando (2curex 202101– before Indivumed + Sysmex Inostics) |
Chief Executive Officer (CEO) |
2cureX ApS |
Denmark |
| Andrews, Ron A. (Ronnie) (Life Technologies 201202– President Medical Sciences before GE Healthcare + CEO of Clarient) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
| Angelin, Bo (Karolinksa Univ Hospital –200707–) |
n. a. |
Karolinska Institutet |
Sweden |
| Anzenberger, Uwe (Link Medical 202104 General Manager at Link Medical Germany) |
General Manager (management) |
Link Medical (Group) |
Norway |
| Armento, Alex (MatTek 202103 CEO) |
Chief Executive Officer (CEO) |
Cellink (Group) |
United States (USA) |
| Armstrong, Frank M. (CuraGen 200603 CEO before Bioaccelerate before Provensis before Bayer before Zeneca) |
Chief Executive Officer (CEO) |
CuraGen (Group) |
United States (USA) |
| Arnesen, Øyvind Kongstun (Ultimovacs AS 201808 CEO) |
Chief Executive Officer (CEO) |
Ultimovacs (Group) |
Norway |
| Arnhög, Mats (Active Biotech 201706 Board Chairman) |
Board member, non-executive |
Active Biotech (Group) |
Sweden |
| Arvidson, Göran (Hansa Medical 201501– CFO before Swedish Orphan Biovitrum + Procardia + Pharmacia) |
Chief Financial Officer (CFO) |
Hansa Medical AB |
Sweden |
| Arvidsson, Lars-Erik (AstraZeneca 200608 VP RnD Lund) |
Research & Development Manager |
AstraZeneca (Group) |
Sweden |
| Asp, Mikael (Oasmia Pharmaceutical 201703 CEO) |
Chief Executive Officer (CEO) |
Oasmia Pharmaceutical AB |
Sweden |
| Astrom, Kalle (Finnvera 201306 Investment Manager) |
Investment Manager |
Finland (govt) |
|
| Atkins, David (Congenica 201801– CEO before Synevo + Leica Biosystems + JnJ/Ortho Clinical Diagnostics) |
Chief Executive Officer (CEO) |
Congenica (Group) |
United Kingdom (GB) |
| Aune, Trond Erik Vee (Vectron Biosolutions 201202 CEO) |
Chief Executive Officer (CEO) |
Vectron Biosolutions AS |
Norway |
| Auster, Martin (Ascendis Pharma 201406– CBO before United Therapeutics as VP Business Development) |
Chief Business Officer (CBO) |
Ascendis Pharma (Group) |
Denmark |
| Avery, Paul (BioStrata 201404– Managing Director before Chempetitive UK + Alto Marketing) |
Public Relations Manager / Investor Relations Manager |
BioStrata Ltd. (Biostrata Marketing) |
United Kingdom (GB) |
| Axelsson, Thomas (Vitrolife AB 201305 CEO) |
Chief Executive Officer (CEO) |
Vitrolife (Group) |
Sweden |
| Bach, Dani (+ND Capital 202105 Partner formerly Aravis + Index Ventures) |
Managing Partner (investment firm) |
+ND Capital (f.k.a. NanoDimension) |
Switzerland |
| Bache, Nicolai (Evosep 201803 Head of Applications) |
Technical Manager |
Evosep ApS |
Denmark |
| Badger, Stephen (Blue Scientific 2013 Founder before Bruker + Veeco) |
Company Founder |
Blue Scientific Ltd. |
United Kingdom (GB) |
| Baier, Manfred (Roche –201112 RETIRES 12/11 as head of Roche Applied Science) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
| Baines, Julian (EKF Diagnostics 201111 CEO) |
Chief Executive Officer (CEO) |
EKF Diagnostics (Group) |
United Kingdom (GB) |
| Bakker, Jeroen (Novo Group 202010 at Novo Seeds) |
Investment Manager |
Novo Group (Group) |
Denmark |
| Baldry, Lindsay (Ramarketing 201603– before Pharma Nord + Admiral PR + Scott Partnership) |
Public Relations Manager / Investor Relations Manager |
Ramarketing (Group) |
United Kingdom (GB) |
| Balendran, Anu (Alligator Bioscience 201805– VP Business Development before AstraZeneca External Innovation Director) |
Business Development Manager / Strategy Manager |
Alligator Bioscience (Group) |
Sweden |
| Bank, Patti (Westwicke Partners 201502– Managing Director before Discern Securities + Pacific Growth Equities/Westbush) |
Managing Director |
ICR (Group) |
United States (USA) |
| Barner, Andreas (Boehringer) |
Board member |
Boehringer Ingelheim (Group) |
Germany |
| Barnes, Duane (Swedish Orphan Biovitrum 202101– Head of North America before UCB Inc + Amgen + Prime Therapeutics) |
Regional manager |
Swedish Orphan Biovitrum (Sobi) (Group) |
Sweden |
| Bataller, Juan (Zeltia 201303 General Manager of Genomica AB) |
General Manager (management) |
PharmaMar (Group) |
Sweden |
| Baum, Charles M. (Mirati Therapeutics 201211– CEO before Pfizer + Schering-Plough) |
Chief Executive Officer (CEO) |
|
|
| Baumgartner, Florian (Spatial Transcirptomics 201812 COO) |
Chief Operating Officer (COO) |
10x Genomics (Group) |
Sweden |
| Bech Jensen, Ejner (Novozymes 201112 VP RnD) |
Research & Development Manager |
Novo Group (Group) |
Denmark |
| Bejker, David (Affibody 201207 CEO before HealthCap) |
Chief Executive Officer (CEO) |
Affibody AB |
Sweden |
| Beller, Steve (Nexstim 201801– VP + Genearl Manager North America) |
Regional manager |
Nexstim (Group) |
United States (USA) |
| Benatti, Luca (EryDel 201804 CEO before Newron CEO + Founder) |
Chief Executive Officer (CEO) |
EryDel S.p.A. |
Italy |
| Benediktsson, Jón Ingi (SEED Capital 201108 Investment Manager) |
Investment Manager |
SEED Capital Denmark (SEED Capital Management I/S) |
Denmark |
| Bengtsson, Per (Karo Bio 201110– CEO before acting CEO before Probi AB + Pharmacia + Ferring + Bionor Immuno) |
Chief Executive Officer (CEO) |
Karo Pharma (Group) |
Sweden |
| Benioff, Marc (Salesforce 202012 CEO) |
Chief Executive Officer (CEO) |
Salesforce.com Inc. (NYSE: CRM) |
United States (USA) |
| Bennett, Eric Paul (Cobo Technologies 201907 Scientific Advisor + Co-Founder) |
Consultant (economic/technology) |
Cobo Technologies ApS |
Denmark |
| Benson, Peter (Sunstone Capital 200705– Managing Partner Life Science Ventures) |
Managing Partner (investment firm) |
Sunstone Life Science (Group) |
Denmark |
| Berg, Kenth (Recipharm 201705 VP Business Management) |
Business Development Manager / Strategy Manager |
Recipharm (Group) |
Sweden |
| Berggren, Maria (Biovitrum 200507–) |
n. a. |
Swedish Orphan Biovitrum (Sobi) (Group) |
Sweden |
| Berggren, Mats (SwedenBIO 200301– CEO) |
Chief Executive Officer (CEO) |
SwedenBIO Service AB |
Sweden |
| Bergman, Karl (Elypta AB 201806 CEO) |
Chief Executive Officer (CEO) |
Elypta AB |
Sweden |
| Bergmann, Ulrich (Univ Oulu 201403 Head of Mass Spec Core Facility) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Oulu |
Finland |
| Bergström, Mats (Halo Genomics 201110– VP Sales before MB Consultant before Gyros + Biotage + Applied Biosystems) |
Sales Manager / Marketing Manager |
Agilent (Group) |
Sweden |
| Berkien, Ton (Nuevolution 201401– CBO before Takeda/Nycomed + Ferring + PricewaterhouseCoopers) |
Chief Business Officer (CBO) |
Nuevolution (Group) |
Denmark |
| Bernardo, Joseph E. (Joe) (Linden Capital 201908 Operating Partner + BCG Senior Advisor before Thermo Fisher + Siemens) |
President/Director/Head Business Group/Unit/Division |
Linden Capital Partners |
|
| Bernstein, Gregory (EQT 202105 Investor + Venture Lead at EQT Ventures) |
Investment Manager |
EQT (Wallenberg family) (Group) |
Sweden |
| Berven, Frode (Univ Bergen 201109 Project Manager Dept Biomedicine PROBE) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Bergen |
Norway |
| Bethell, Richard (Medivir 201611 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Medivir (Group) |
Sweden |
| Birk, Henrik (Bavarian Nordic 201701– COO joined in 2008 before Coloplast) |
Chief Operating Officer (COO) |
Bavarian Nordic (Group) |
Denmark |
| Birndorf, Howard C. (Nanogen 200503) |
n. a. |
Elitech (Group) |
United States (USA) |
| Birt, Jonathan (Consilium 202008) |
Public Relations Manager / Investor Relations Manager |
Consilium Strategic Communications Ltd. (CSC) |
United Kingdom (GB) |
| Bischofberger, Norbert (Kronos Bio 202010 CEO before Gilead Sciences 200903 EVP R&D CSO) |
Chief Executive Officer (CEO) |
Kronos Bio Inc. (Nasdaq: KRON) |
United States (USA) |
| Bisgaard, Peter (Novo Group 201102 Partner Novo A/S) |
Partner (venture partner) |
Novo Group (Group) |
Denmark |
| Bizzari, Jean-Pierre (Nordic Nanovector 201605– Board Memeber before Celgene + Sanofi-Aventis) |
Board member |
Nordic Nanovector (Group) |
Norway |
| Bjerke, Torbjørn (Karolinska Institutet 201306 CEO of Karolinska Development before Orexo CEO before Biolipox CEO) |
Chief Executive Officer (CEO) |
Karolinska Development AB (Nasdaq Stockholm: KDEV) |
Sweden |
| Bjerke, Ulrica (Arctic 201805 Fund Manager of AALS Fund) |
n. a. |
Arctic (Group) (NO) |
Norway |
| Björk, Erik (Medivir 201801– CFO before AstraZeneca AB + Procter & Gamble) |
Chief Financial Officer (CFO) |
Medivir (Group) |
Sweden |
| Björklund, Håkan (Lundbeck 201310 Board Chairman before Nycomed 1999–2011 CEO) |
Chief Executive Officer (CEO) |
Takeda (Group) |
Switzerland |
| Björklund, Ulf (Aprea 201112 CEO) |
Chief Executive Officer (CEO) |
Aprea AB |
Sweden |
![[LSS] Life-Sciences-Scandinavia.com - The Scandinavian Life Sciences Web Portal](/images/basics/lss-life-sciences-scandinavia-portal-logo-2019.png){kind=logo}
![Picture [iito] Made Without Love 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-made-without-love.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
